Technology provides non-invasive treatment for congenital heart disease patients
FDA says do not drink ‘Real Water’ brand alkaline water
30 April 2021New wearable sensor tracks children’s suffering with eczema, and adults with itch symptoms
30 April 2021Technology provides non-invasive treatment for congenital heart disease patients
New study results validate the effectiveness of the Medtronic Harmony transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR). The Harmony TPV is designed to be a less invasive treatment option for patients with irregularity in their right ventricular outflow tract (RVOT) needing pulmonary valve placement to restore valve function. The results of this study are being presented as late-breaking clinical science today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.
